Y2KGIL and Investable Solutions Sign Memorandum of Understanding to Boost Bio Startups

Aiming to support the global expansion of startups in the bio-health sector, Y2KGIL and Investable Solutions have recently signed a Memorandum of Understanding (MOU). 

Y2KGIL, a renowned consulting firm, and Investable Solutions, a global investment institution based in Israel and the United States, announced their investment strategies and directions for the year at the ‘Accelerating Day’ event(1). The event, held on June 19, 2024, was organized by the Korea Institute of Toxicology (KIT), a government-funded research institute.

The MOU was signed in June 2024 to support the global commercialization of startups participating in the DIPS 1000+ project. The DIPS 1000+ project, led by the KIT, is a government initiative aimed at nurturing promising startups in the bio-health sector(1).

The partnership between Y2KGIL and Investable Solutions will provide comprehensive and professional support for the global commercialization of startups. This includes active promotion of technology transfer and M&A with global pharmaceutical giants, establishment and collaboration with local corporations in the United States, global licensing and business consulting, and domestic and foreign investment linkage.

The collaboration is expected to pave the way for new opportunities for bio startups struggling with investment difficulties. By leveraging the expertise and global network of both Y2KGIL and Investable Solutions, startups can expect to receive substantial support in their global business expansion efforts.

This strategic partnership is a testament to the commitment of Y2KGIL and Investable Solutions to foster innovation and growth in the bio-health sector. It is anticipated that this collaboration will bring about significant advancements in the industry and contribute to the global success of bio startups.

There is no previous post.

Y2KGIL and Hallym University Sign Memorandum of Understanding